Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
BioMarin Pharmaceutical Inc. (BMRN) had Weighted-Average Shares Outstanding (Diluted) of 197.09M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$825.41M |
|
$240.53M |
|
$150.09M |
|
$675.32M |
|
$548.52M |
|
$276.89M |
|
$20.98M |
|
$297.87M |
|
$297.87M |
|
$240.53M |
|
$240.53M |
|
$240.53M |
|
$240.53M |
|
$276.89M |
|
$294.10M |
|
191.91M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
197.09M |
$1.25 |
|
$1.23 |
|
| Balance Sheet Financials | |
$3.81B |
|
$1.03B |
|
$3.65B |
|
$7.46B |
|
$684.25M |
|
$596.16M |
|
$744.98M |
|
$1.43B |
|
$6.03B |
|
$5.59B |
|
$6.03B |
|
192.00M |
|
| Cash Flow Statement Financials | |
$359.67M |
|
$-40.83M |
|
$-43.38M |
|
$942.84M |
|
$1.21B |
|
$270.97M |
|
$85.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.56 |
|
-- |
|
-- |
|
0.09 |
|
0.10 |
|
81.82% |
|
33.55% |
|
33.55% |
|
-- |
|
36.09% |
|
29.14% |
|
$325.80M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.11 |
|
0.96 |
|
93.32 |
|
3.99% |
|
4.30% |
|
3.23% |
|
3.63% |
|
$31.39 |
|
$1.65 |
|
$1.82 |
|